| 000 | 01779 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514232010.0 | ||
| 264 | 0 | _c20050923 | |
| 008 | 200509s 0 0 eng d | ||
| 022 | _a0340-6245 | ||
| 024 | 7 |
_a10.1160/TH04-09-0608 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLanger, Robert D | |
| 245 | 0 | 0 |
_aBaseline associations between postmenopausal hormone therapy and inflammatory, haemostatic, and lipid biomarkers of coronary heart disease. The Women's Health Initiative Observational Study. _h[electronic resource] |
| 260 |
_bThrombosis and haemostasis _cJun 2005 |
||
| 300 |
_a1108-16 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aC-Reactive Protein _xmetabolism |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aCoronary Disease _xblood |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 |
_aEstrogen Replacement Therapy _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHemostasis |
| 650 | 0 | 4 |
_aHomocysteine _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation Mediators _xmetabolism |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xblood |
| 700 | 1 | _aPradhan, Aruna D | |
| 700 | 1 | _aLewis, Cora E | |
| 700 | 1 | _aManson, JoAnn E | |
| 700 | 1 | _aRossouw, Jacques E | |
| 700 | 1 | _aHendrix, Susan L | |
| 700 | 1 | _aLaCroix, Andrea Z | |
| 700 | 1 | _aRidker, Paul M | |
| 773 | 0 |
_tThrombosis and haemostasis _gvol. 93 _gno. 6 _gp. 1108-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1160/TH04-09-0608 _zAvailable from publisher's website |
| 999 |
_c15626718 _d15626718 |
||